Invest in intelligence that delivers

Contact
Search
Close this search box.

Perspective
is everything.

Across the pharma lifecycle, an accurate and complete market view is essential to stay ahead of the curve and uncover emerging healthcare trends.

Visit our portal

Think beyond the brand.

The more you understand the landscape, the better you can align with market needs and gain a competitive edge.

Identify:

  • Unmet market, prescriber, and patient needs 
  • Disconnect between what prescribers say versus what they do 
  • Gaps, threats, and disruptors 

Broaden your
perspective,
with Spherix.

We combine robust, independent market data with deep therapeutic expertise and impeccable focus on delivering commercial value.

Harness the power of holistic market intelligence. Make better decisions and unlock opportunities.

We view the market landscape through the lens of your business and deliver customized strategic advisory services.

Spherix delivers:

Market Insights

Gain an unbiased perspective of the market and its potential, independently assess launches, understand the patient journey and prescribers' perspectives, and gauge the impact of disruptive events.

Strategic Sessions

Interactive on-site or virtual  sessions with Spherix therapeutic experts, highlighting commercially relevant analyses, contextual data, and custom insights tailored to your business.

Advisory Services

Fortify your strategy and tactics with our industry experts who are well-equipped to deliver strategic advisory services across the product lifecycle.

Spherix is dedicated to the therapeutic areas we cover.

Learn more about the specialty markets we cover

Dermatology Indications Covered:

  • Alopecia Areata (AA)
  • Atopic Dermatitis (AD)
  • Hidradenitis Suppurativa (HS)
  • Plaque Psoriasis (PsO)
  • Prurigo Nodularis (PN)
  • Vitiligo

Visit the Spherix portal for the full spectrum of our Dermatology offering

Gastroenterology Indications Covered:

  • Celiac Disease
  • Clostridioides Difficile (Cdiff)
  • Crohn’s Disease (CD)
  • Eosinophilic Esophagitis (EoE)
  • Irritable Bowel Syndrome (IBS)
  • Metabolic dysfunction-associated steatotic liver disease/ metabolic dysfunction-associated steatohepatitis (MASLD/MASH) (previously NAFLD/NASH)
  • Primary Biliary Cholangitis (PBC)
  • Ulcerative Colitis (UC)

Visit the Spherix portal for the full spectrum of our Gastroenterology offering

Rheumatology Indications Covered:

  • ANCA-associated Vasculitis
  • Ankylosing Spondylitis And Non-radiographic Axial Spondylitis (AS and nr-axSpA)
  • Cutaneous Lupus Erythematosus (CLE)
  • Dermatomyositis (DM)
  • Giant Cell Arteritis (GCA)
  • Lupus Nephritis (LN)
  • Polymyalgia Rheumatica (PMR)
  • Psoriatic Arthritis (PsA)
  • Rheumatoid Arthritis (RA)
  • Sjögren’s Syndrome (SjS)
  • Systemic Sclerosis (SSc)
  • Systemic Lupus Erythematosus (SLE)

Visit the Spherix portal for the full spectrum of our Rheumatology offering

Nephrology Indications Covered:

  • Alport Syndrome
  • Bone and Mineral Metabolism
  • Chronic Kidney Disease (CKD)
  • CKD-associated Pruritus (CKD-aP)
  • Complement 3 Glomerulopathy (C3G)
  • Diabetic Kidney Disease (DKD)
  • Dialysis
  • Focal Segmental Glomerulosclerosis (FSGS)
  • Glomerular Disease and Nephritis
  • Hyperkalemia
  • Hyperphosphatemia
  • IgA Nephropathy (IgAN)
  • Lupus Nephritis (LN)
  • Membranous Nephropathy (MN)
  • Polycystic Kidney Disease (ADPKD)
  • Renal Anemia

Visit the Spherix portal for the full spectrum of our Nephrology offering

Neurology Indications Covered:

  • Alzheimer’s Disease (AD)
  • Amylotrophic Lateral Sclerosis (ALS)
  • Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • Epilepsy
  • Generalized Myasthenia Gravis (gMG)
  • Huntington’s Disease (HD)
  • Migraine
  • Multiple Sclerosis (MS)
  • Parkinson’s Disease (PD)

Visit the Spherix portal for the full spectrum of our Neurology offering

Ophthalmology Indications Covered:

  • Diabetic Macular Edema (DME)
  • Diabetic Retinopathy (DR)
  • Dry Age-related Macular Degeneration (AMD)
  • Geographic Atrophy (GA)
  • Gene Therapies In Retinal Disorders
  • Neovascular Age-related Macular Degeneration (nAMD)

Visit the Spherix portal for the full spectrum of our Ophthalmology offering

NEW in 2024!

Hematology Indications Covered:

  • Autoimmune Hemolytic Anemia (AIHA)
  • Cold Agglutinin Disease (CAD)
  • Hemophilia
  • Immune Thrombocytopenic Purpura (ITP)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Sickle Cell Disease (SCD)
  • Thalassemia
  • Thrombotic thrombocytopenic purpura (ITP)

Visit the Spherix portal for the full spectrum of our Hematology offering

Capitalize on commercially relevant insights and advisory services across the pharma lifecycle.

Independent, holistic intelligence informs tailored support that matches the needs of your business.
Understand the prescriber’s perspective of the competitive landscape.
Reveal the ‘why’ behind treatment decisions and understand the patient journey.
Independently assess launches and benchmark history of analogs.
Gain an unbiased perspective of the market and its potential.
Add context to trending topics and gauge the impact of disruptive events.

Shape what’s next with market intelligence that is trusted and influential.

We work with 17 of the top 20 pharma/biotech organizations, and our expertise is a go-to resource for leading brands, industry media outlets, financial analysts, professional organizations, and patient advocacy groups.
Learn more about the Spherix offering
  • Pharma
  • Key Opinion Leaders
  • Professional Organizations
  • Media Outlets
  • Patient Advocacy Groups
  • Financial Analyst Firms

Our therapeutic experts are always just a click or call away...

  • Plugged into the ever-evolving landscape
  • Ready to provide an unbiased view of the landscape
  • Insightfully answer real-time questions
  • Highlight opportunities
  • Identify disruptors
Contact us
“Spherix's Dynamix studies provide us invaluable insights into the physician-patient exchange that guides both our patient-facing programs and our interactions with pharma partners. Their survey reports highlight needs that cannot be assessed by EMR data alone. They also reveal information and resources that patients are not receiving, gaps in support that we can fill. These reports are a glimpse into the patient exam room that we can't get anywhere else.”
Pharmaceutical In-Line Brand Commercial Strategy Lead
"Spherix is unparalleled in their timely and accurate market snapshots with comprehensive feedback on physicians’ impressions, use patterns and projected use of key drugs across the therapeutic categories covered. They are my go-to source when I want insights as to how to model a launch, a competitive dynamic or understand awareness around pipeline agents.”
Senior Biotech Analyst at a Leading Investment Bank
"Spherix offerings have provided us with an external source of reference which, when compared with our custom market research, led us to include a potentially lucrative segment of physicians in our target list leading to increased growth.”
Pharmaceutical In-Line Brand Commercial Strategy Lead
Previous
Next

Media

View all media

Talk to an expert

Gianna Melendez
Franchise Head, Dermatology

Contact

Jim Hickey
Franchise Head, Gastroenterology

Contact

Maxine Yarnall
Franchise Head, Rheumatology

Contact

Meghan Weiss
Franchise Head, Nephrology

Contact

Blaine Cloud, PhD
Franchise Head, Neurology

Contact

Blaine Cloud, PhD
Franchise Head, Ophthalmology

Contact
Tucker Hurtado
Launch Franchise Head, Hematology
Contact
Sign up for alerts, market insights and exclusive content in your inbox.
Subscribe
Linkedin

Download our publication plan

or

Visit our portal for the searchable format

©2024 Spherix. All Rights Reserved.

Site Map

Sign up for alerts, market insights and exclusive content in your inbox.

Spherix is excited to announce our expansion into an additional, rapidly evolving specialty market:

HEMATOLOGY

Throughout 2024, we will be publishing over
10 groundbreaking studies covering a wide range of indications within classical hematology.